Analyst Reco. Camurus AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 11:29:39 2024-06-07 am EDT			5-day change	1st Jan Change
599 ^SEK	+1.53%		+3.10%	+11.34%

May. 23	Camurus' Rare Growth Disorder Drug Accepted for Review in EU	MT
May. 23	Camurus Receives EMA Acceptance of MAA Filing for Octreotide SC Depot for the Treatment of Acromegaly	CI

ANALYST RECOMMENDATIONS : AT&T, BancorpSouth Bank, CMO Group, Magnite, Textron...	21-08-31
Camurus AB Announces Publication of Phase 3 Study Results Showing Long-Term Safety, Efficacy and High Rates of Patient Satisfaction with Buvidal®	19-06-04	CI

No results for this search